KLF4 and neoplasm: KLF4, a vital regulator of the NOTCH pathway, promotes ineffective angiogenesis in tumors via the NOTCH pathway, leading to hypoxia and diminished tumor growth (73), and KLF4 also inhibits NOTCH-1 in combination with SP3 transcription (74).